Bringing the fundamentals into focus…
Back to Akebia Therapeutics, Inc.
How Akebia Therapeutics, Inc. stacks up
AKBA · against 552 other Healthcare companies listed in US-listed
Overall
24/ 100
Near the bottom of its peers.
Ranked #488 of 553 · scores higher than 9% of peers
Bars: peers in each 10-point band of the overall score70 peers with an overall score of 20–29, including AKBA · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around AKBA| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 595M USD | 97 | 96 | 98 | 99 | 0 / 2 | |
| 1 | 261M USD | 97 | 93 | — | 98 | 0 / 2 | |
| 3 | 2.1B USD | 96 | 96 | 99 | 93 | 0 / 2 | |
| 4 | 1.5B USD | 93 | 94 | 91 | 93 | 0 / 2 | |
| 5 | 609M USD | 91 | 95 | 99 | 99 | 0 / 2 | |
| 477 | 2.0B USD | 26 | 8 | 56 | 14 | 2 / 2 | |
| 485 | 2.3B USD | 25 | 8 | 0 | 4 | 0 / 2 | |
| 485 | 888M USD | 25 | 8 | 3 | 6 | 0 / 2 | |
| 485 | 474M USD | 25 | 8 | 78 | 11 | 2 / 2 | |
| 488 | 201M USD | 24 | 8 | 48 | 29 | 2 / 2 | |
| 488 | 487M USD | 24 | 8 | 63 | 12 | 2 / 2 | |
| 488 | 33.3B USD | 24 | 8 | 43 | 27 | 2 / 2 | |
| 488 | 264M USD | 24 | 8 | 5 | 2 | 0 / 2 | |
| 488 | 27M USD | 24 | 8 | 35 | 13 | 1 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score